Open Access
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(05): 683-687
DOI: 10.4103/ijmpo.ijmpo_216_19
Original Article

Utility of Immunohistochemistry on Bone Marrow Trephine Biopsy for the Diagnosis and Classification of Acute Leukemia

H Sudha Rani
Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India
,
Monalisa Hui
Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India
,
Megha S Uppin
Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India
,
Shantveer G Uppin
Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India
,
G Sadashivudu
Department of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India
,
Tara Roshni Paul
Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India
› Institutsangaben

Financial support and sponsorship Nil.
Preview

Abstract

Background: Bone marrow examination is an essential diagnostic tool in acute leukemia for the determination of lineage of blasts by flow cytometry or immunophenotyping. In cases of dry tap or where facilities of flow cytometry is not available, immunohistochemistry (IHC) on trephine biopsy sections can be used as a supportive tool to diagnose and classify acute leukemia. Materials and Methods: The giemsa-stained peripheral smears and bone marrow aspirate/imprints smears were retrospectively evaluated. IHC was done on trephine biopsy sections using a panel of antibodies which included CD34, MPO, CD117, Tdt, CD3, CD20, PAX5, and CD10 Results: Of the 29 cases diagnosed by IHC on trephine sections, 25 cases could be accurately classified based on the expression of myeloid and lymphoid markers. Majority of the acute lymphoblastic leukemia (ALL) were of B-cell lineage (81.25%), and almost half of the B-ALL were common acute lymphoblastic leukemia-associated antigen positive. Conclusion: IHC on trephine biopsy facilitates the confirmation and subtyping of leukemia in more than 85% cases. A limited panel of antibodies using CD34, MPO, TdT, CD3 CD20, PAX 5, and CD10 can be used for subtyping of leukemias in trephine biopsy sections, especially in centers with limited resources. It obviates the need for a repeat bone marrow procedure where material is not available for flow cytometry.



Publikationsverlauf

Eingereicht: 23. Oktober 2019

Angenommen: 01. Juni 2019

Artikel online veröffentlicht:
17. Mai 2021

© 2020. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India